Bernhardt, G <br/><br/>
[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. III. Detailed evaluation of the antitumor activity of the enantiomeric complexes on the human NIH:OVCAR-3 ovarian cancer cell line.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  1992 
 - 209-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0171-5216 
<br/><br/><label>Standard No.: </label>10.1007/BF01410136  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Buthionine Sulfoximine<br/>Cell Line<br/>Cisplatin--pharmacology<br/>Female<br/>Glutathione--metabolism<br/>Humans<br/>Methionine Sulfoximine--analogs & derivatives<br/>Organoplatinum Compounds--pharmacology<br/>Ovarian Neoplasms--drug therapy<br/>Stereoisomerism<br/>Structure-Activity Relationship<br/>Tumor Cells, Cultured--drug effects